-
Shaping the Future of Lung Cancer Care: Dr. Caicun Zhou on IASLC’s 50th Anniversary and the Promise of HARMONi2
The International Association for the Study of Lung Cancer (IASLC), founded in 1974, has grown into a global organization with over 10,000 members from more than 100 countries and regions. In 2023, Dr. Caicun Zhou from Shanghai Pulmonary Hospital, Tongji University School of Medicine was elected as the IASLC President-Elect for 2023-2025 and will serve…
-
From Curious Learner to Pioneer: Dr. Jie Chen’s Medical Evolution
As we step further into the 21st century, the field of medicine has undergone tremendous changes. Among the many advancements, a generation of compassionate and skilled doctors has emerged, dedicated to the wellbeing of their patients and their nation. The phrase “a doctor’s heart is like a parent’s” perfectly captures this essence. In the Oncology…
-
Serum Albumin as a Prognostic Factor in Acute Myeloid Leukemia
In June 2024, Blood Science published a pivotal study led by Dr. Hui Wei from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , investigating the prognostic significance of serum albumin levels in patients with acute myeloid leukemia (AML). AML is a highly aggressive hematological…
-
Plerixafor-Based Mobilization and Increased Mononuclear Cell Counts: Risk Factors for Engraftment Syndrome Post-Autologous Hematopoietic
In June 2024, Blood Science published a significant study led by Dr. Xiaohui Zhang and colleagues from the Peking University People’s Hospital, focusing on the incidence and risk factors of engraftment syndrome (ES) following autologous hematopoietic stem cell transplantation (ASCT) in the era of plerixafor-based mobilization. ASCT remains a critical therapy for hematologic malignancies, particularly…
-
2024 Nobel Prize | MicroRNAs (miRNAs) and Liver Diseases
RNAs serve diverse functions, with one of the key roles being to guide protein synthesis, which is fundamental to life. MicroRNAs are a class of endogenous non-coding RNAs that play…
-
New Characteristics of BL/BLI Compounds Targeting Non-KPC Enterobacterales
Background The rise of carbapenem-resistant Gram-negative organisms (CRO) poses a significant public health challenge, prompting researchers to focus on developing new antimicrobial agents and enhancing infection control and antimicrobial stewardship…
-
Ivosidenib in Chinese Patients with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia: A Registry Study
In June 2024, Blood Science published an important study led by Dr. Jie Jin and colleagues from the The First Affiliated Hospital, Zhejiang University School of Medicine, investigating the safety, pharmacokinetics, and efficacy of ivosidenib in Chinese patients with relapsed or refractory (R/R) isocitrate dehydrogenase 1 (IDH1)-mutated acute myeloid leukemia (AML). AML, a heterogeneous and…
-
Subcutaneous Daratumumab in Chinese Patients with Relapsed/Refractory Multiple Myeloma: A Phase 1 Study
In April 2024, the journal Blood Science published an important study led by Dr. Gang An and colleagues from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, investigating the use of subcutaneous daratumumab in Chinese patients with relapsed/refractory multiple myeloma (R/R MM). Multiple myeloma is…
Connecting Medical Expertise through Media